Literature DB >> 30626665

Unique Transcriptional Architecture in Airway Epithelial Cells and Macrophages Shapes Distinct Responses following Influenza Virus Infection Ex Vivo.

Joel Z Ma1, Wy Ching Ng2, Luke Zappia3, Linden J Gearing4,5, Moshe Olshansky6, Kym Pham4,5, Karey Cheong4,5, Arthur Hsu4,5, Stephen J Turner6, Odilia Wijburg2, Sarah L Londrigan2, Andrew G Brooks2, Patrick C Reading1,7.   

Abstract

Airway epithelial cells and macrophages differ markedly in their responses to influenza A virus (IAV) infection. To investigate transcriptional responses underlying these differences, purified subsets of type II airway epithelial cells (ATII) and alveolar macrophages (AM) recovered from the lungs of mock- or IAV-infected mice at 9 h postinfection were subjected to RNA sequencing. This time point was chosen to allow for characterization of cell types first infected with the virus inoculum, prior to multicycle virus replication and the infiltration of inflammatory cells into the airways. In the absence of infection, AM predominantly expressed genes related to immunity, whereas ATII expressed genes consistent with their physiological roles in the lung. Following IAV infection, AM almost exclusively activated cell-intrinsic antiviral pathways that were dependent on interferon (IFN) regulatory factor 3/7 (IRF3/7) and/or type I IFN signaling. In contrast, IAV-infected ATII activated a broader range of physiological responses, including cell-intrinsic antiviral pathways, which were both independent of and dependent on IRF3/7 and/or type I IFN. These data suggest that transcriptional profiles hardwired during development are a major determinant underlying the different responses of ATII and AM to IAV infection.IMPORTANCE Airway epithelial cells (AEC) and airway macrophages (AM) represent major targets of influenza A virus (IAV) infection in the lung, yet the two cell types respond very differently to IAV infection. We have used RNA sequencing to define the host transcriptional responses in each cell type under steady-state conditions as well as following IAV infection. To do this, different cell subsets isolated from the lungs of mock- and IAV-infected mice were subjected to RNA sequencing. Under steady-state conditions, AM and AEC express distinct transcriptional activities, consistent with distinct physiological roles in the airways. Not surprisingly, these cells also exhibited major differences in transcriptional responses following IAV infection. These studies shed light on how the different transcriptional architectures of airway cells from two different lineages drive transcriptional responses to IAV infection.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  RNA sequencing; epithelial cell; influenza; lung; macrophage; mouse model

Mesh:

Substances:

Year:  2019        PMID: 30626665      PMCID: PMC6401432          DOI: 10.1128/JVI.01986-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Uncovering the global host cell requirements for influenza virus replication via RNAi screening.

Authors:  Silke Stertz; Megan L Shaw
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

3.  MATCH: A tool for searching transcription factor binding sites in DNA sequences.

Authors:  A E Kel; E Gössling; I Reuter; E Cheremushkin; O V Kel-Margoulis; E Wingender
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

5.  Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation.

Authors:  Aidan S Hancock; Christopher J Stairiker; Alina C Boesteanu; Elisa Monzón-Casanova; Sebastian Lukasiak; Yvonne M Mueller; Andrew P Stubbs; Adolfo García-Sastre; Martin Turner; Peter D Katsikis
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

6.  Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus.

Authors:  Michelle D Tate; Heidi C Schilter; Andrew G Brooks; Patrick C Reading
Journal:  Viral Immunol       Date:  2011-04       Impact factor: 2.257

7.  Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity.

Authors:  Jennifer E Fenner; Robyn Starr; Ann L Cornish; Jian-Guo Zhang; Donald Metcalf; Robert D Schreiber; Kathleen Sheehan; Douglas J Hilton; Warren S Alexander; Paul J Hertzog
Journal:  Nat Immunol       Date:  2005-11-27       Impact factor: 25.606

Review 8.  Epigenetic regulation of macrophage polarization and function.

Authors:  Lionel B Ivashkiv
Journal:  Trends Immunol       Date:  2012-12-04       Impact factor: 16.687

Review 9.  Influenza virus replication in macrophages: balancing protection and pathogenesis.

Authors:  Troy D Cline; Donald Beck; Elizabeth Bianchini
Journal:  J Gen Virol       Date:  2017-09-08       Impact factor: 3.891

10.  Data-based filtering for replicated high-throughput transcriptome sequencing experiments.

Authors:  Andrea Rau; Mélina Gallopin; Gilles Celeux; Florence Jaffrézic
Journal:  Bioinformatics       Date:  2013-07-02       Impact factor: 6.937

View more
  6 in total

Review 1.  Cytoplasm and Beyond: Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I.

Authors:  GuanQun Liu; Yan Zhou
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

2.  Airway Exosomes Released During Influenza Virus Infection Serve as a Key Component of the Antiviral Innate Immune Response.

Authors:  James G Bedford; Giuseppe Infusini; Laura F Dagley; Fernando Villalon-Letelier; Ming Z M Zheng; Vicki Bennett-Wood; Patrick C Reading; Linda M Wakim
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

3.  Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.

Authors:  Jessica K Fiege; Joshua M Thiede; Hezkiel Arya Nanda; William E Matchett; Patrick J Moore; Noe Rico Montanari; Beth K Thielen; Jerry Daniel; Emma Stanley; Ryan C Hunter; Vineet D Menachery; Steven S Shen; Tyler D Bold; Ryan A Langlois
Journal:  PLoS Pathog       Date:  2021-01-28       Impact factor: 6.823

4.  Cellular Protein Phosphatase 2A Regulates Cell Survival Mechanisms in Influenza A Virus Infection.

Authors:  Vanessa Gerlt; Juliane Mayr; Juliana Del Sarto; Stephan Ludwig; Yvonne Boergeling
Journal:  Int J Mol Sci       Date:  2021-10-16       Impact factor: 5.923

5.  Cell type- and replication stage-specific influenza virus responses in vivo.

Authors:  Elizabeth J Fay; Stephanie L Aron; Marissa G Macchietto; Matthew W Markman; Katharina Esser-Nobis; Michael Gale; Steven Shen; Ryan A Langlois
Journal:  PLoS Pathog       Date:  2020-08-13       Impact factor: 6.823

6.  Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.

Authors:  Sushila A Toulmin; Chaitali Bhadiadra; Andrew J Paris; Jeffrey H Lin; Jeremy Katzen; Maria C Basil; Edward E Morrisey; G Scott Worthen; Laurence C Eisenlohr
Journal:  Nat Commun       Date:  2021-06-28       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.